POLYNEUROMYOPATHY OF CRITICAL CONDITIONS: POSSIBILITIES OF EARLY REHABILITATION


Cite item

Full Text

Abstract

Due to the improvement of resuscitation technologies growth of the persons which drove out of critical conditions is noted. More than a half of them have the permanent neuromuscular violations which appeared in the office of intensive therapy, and significantly limit physical activity of these patients further. The etiology of a polyneuromyopathy of critical conditions (PMKS) can be explained by many factors and is also connected both with the direct reasons which are directly defining defeat of the neuro and muscular device, and mediated, connected with the patient’s immobility of a patient in the critical condition. The undertaken review allows to present a situation concerning an etiology, pathogenesis, epidemiology, diagnostics and medical strategy of patients with PMKS.

About the authors

Rustem T Gaifutdinov

Kazan state medical University

Email: Gaifutdinov69@mael.ru
Department of neurology, neurosurgery and medical genetics Каzan, Butlerov street, 49

References

  1. Алашеев А.М. Синдром нервно-мышечных нарушений при критическом состоянии в нейрореаниматологии: Автореф. …канд. мед. наук. Екатеринбург, 2006. 23 с.
  2. Алашеев А.М., Белкин A.A., Зислин Б.Д. Полиневромиопатия критических состояний // Анналы неврологии. 2013. Т 7, №1, С.12-18.
  3. Белкин А.А., Алашев А.М., Давыдова Н.С. и др. Обоснование реанимационной реабилитации в профилактике и лечении синдрома «после интенсивной терапии» (ПИТ-синдром) // Вестник восстановительной медицины. 2014. Т. 1. С. 37─43.
  4. Bednarík J., Vondracek P., Dusek L. et al. Risk factors for critical illness polyneuromyopathy // J. Neurol. 2008. Vol. 252, №3. Р. 343─351.
  5. Bodine S.C., Stitt T.N., Gonzalez M. et al. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo // Nat. Cell. Biol. 2001, №3. P. 1014-1019.
  6. Bolton C.F., Gilbert J.J, Hahn A.F., Sibbald W.J. Polyneuropathy in critically ill patients // J. Neurol. Neurosurg. Psychiatr. 1984. Vol.47, №11. Р. 1223-1231.
  7. Bolton C.F. Neuromuscular manifestations of critical illness // Muscle Nerve. 2005. Vol.32, №2. Р. 140-163.
  8. De Jonghe B., Sharshar T., Lefaucheur J.P., Authier F.J. et al. Paresis acquired in the intensive care unit: a prospective multicenter study // J.A.M.A. 2002. Vol.288, №22. P. 2859-2867.
  9. De Letter M.A., Schmitz P.I., Visser L.H. et al. Risk factors for the development of polyneuropathy and myopathy in critically ill patients // Crit. Care. Med. 2001. Vol. 29. P. 2281-2286.
  10. Eddy Fan M.D. Critical Illness Neuromyopathy and the Role of Physical Therapy and Rehabilitation in Critically Ill Patients // Respiratory Care. 2012. Vol.57, № 6. Р. 933-946.
  11. Fan E., Zanni J.M., Dennison C.R. et al. Critical illness neuromyopathy and muscle weakness in patients in the intensive care unit // AACN Adv. Crit. Care. 2009. Vol. 20, №3. Р. 243-253.
  12. Fan E. What is stopping us from early mobility in the intensive care unit? // Crit. Care. Med. 2010. Vol. 38, № 11. Р. 2254-2255.
  13. Ferrando A.A., Lane H.W., Stuart C.A. et al. Prolonged bed rest decreases skeletal muscle and whole body protein synthesis // Am. J. Physiol. 1996. Vol. 270, №4. Р. 627-633.
  14. Friedrich O., Hund E., Weber C. et al. Critical illness myopathy serum fractions affect membrane excitability and intracellular calcium release in mammalian skeletal muscle // J. Neurol. 2004. Vol.251, №1. Р. 53─65.
  15. Garnacho-Montero J., Madrazo-Osuna J., García-Garmendia J.L. et al. Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients // Intensive Care. Med. 2001. Vol. 27, Р. 1288-1296.
  16. Girard T.D., Kress J.P., Fuchs B.D. еt al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial // Lancet. 2008. Vol.371, № 9607. P.126-134.
  17. Goodman B.P., Boon A.J. Critical illness neuromyopathy // Phys. Med. Rehabil. Clin. N. Am. 2008. Vol.19, № 1. Р. 97-110.
  18. Gosselink R., Bott J., Johnson M. et al. Physiotherapy for adult patients with critical illness: recommendations of the European Respiratory Society and European Society of Intensive Care Medicine Task Force on Physiotherapy for Critically Ill Patients // Intensive Care. Med. 2008.Vol. 34. P. 1188-1199.
  19. Gerovasili V., Stefanidis K., Vitzilaios K. et al. Electrical muscle stimulation preserves the muscle mass of critically ill patients: a randomized study // Crit. Care. 2009. Vol. 13, № 5. Р. 161.
  20. Hamburg N.M., McMackin C.J., Huang A.L. et al. Physical inactivity rapidly induces insulin resistance and microvascular dysfunction in healthy volunteers // Arterioscler. Thromb. Vasc. Biol. 2007. Vol. 27, №12. Р. 2650-2656.
  21. Herkert M., Becker C., Hacke W. A humoral neurotoxic factor in sera of patients with critical illness polyneuropathy // Ann. Neurol. 1996. Р.539.
  22. Hermans G., de Jonghe B., Bruyninckx F., Berghe G. Clinical review: critical illness polyneuropathy and myopathy // Crit Care. 2008. Vol.12, №6. Р. 238.
  23. Hermans G., de Jonghe B., Bruyninckx F., van den Berghe G. Interventions for preventing critical illness polyneuropathy and critical illness myopathy // Cochrane Database Syst. Rev. 2009. Vol.1. CD006832
  24. Hermans G., Wilmer A., Meersseman W. et al. Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit // Am. J. Respir. Crit. Care. Med. 2007. Vol.175, № 5. Р. 480-489.
  25. Herridge M.S., Cheung A.M., Tansey C.M. et al. One-year outcomes in survivors of the acute respiratory distress syndrome // N. Engl. J. Med. 2003. Vol. 348, № 8. Р. 683-693.
  26. Hopkins R.O., Spuhler V.J., Thomsen G.E. Transforming ICU culture to facilitate early mobility // Crit. Care. Clin. 2007. Vol.23, № 1. Р. 81-96.
  27. Kasper C.E., Talbot L.A., Gaines J.M. Skeletal muscle damage and recovery // AACN Clin. Issues. 2002. Vol.13, №2. Р. 237-247.
  28. Khan J., Harrison T.B., Rich M.M., Moss M. Early development of critical illness myopathy and neuropathy in patients with severe sepsis // Neurology. 2006. Vol.67, №8. Р. 1421-1425.
  29. Koo K.K., Choong K., Fan E. Prioritizing rehabilitation strategies in the care of the critically ill // Crit. Care. Rounds. 2011. Vol.8, №4. Р. 1-7.
  30. Latronico N., Shehu I., Seghelini E. Neuromuscular sequelae of critical illness // Curr. Opin. Crit. Care. 2005. Vol.11. P. 381-390.
  31. Martin G.S., Mannino D.M., Eaton S., Moss M. The epidemiology of sepsis in the United States from 1979 through 2000 // N. Engl. J. Med. 2003. Vol. 348, №16. Р. 1546-1554.
  32. Martin U.J., Hincapie L., Nimchuk M. et al. Impact of whole-body rehabilitation in patients receiving chronic mechanical ventilation // Crit. Care. Med. 2005. Vol.33, №10. Р. 2259-2265.
  33. Morris P.E., Goad A., Thompson C. et al. Early intensive care unit mobility therapy in the treatment of acute respiratory failure // Crit. Care. Med. 2008. Vol. 34.№7. Р.1188-1199.
  34. Nanas S., Kritikos K., Angelopoulos E. et al. Predisposing factors for critical illness polyneuromyopathy in a multidisciplinary intensive care unit // Acta. Neurol. Scand. 2011. Vol. 118, № 3. Р. 175-181.
  35. Needham D.M. Mobilizing patients in the intensive care unit: improving neuromuscular weakness and physical function // JAMA. 2008. Vol. 300, №14. Р. 1685-1690.
  36. Needham D.M., Korupolu R., Zanni J.M. et al. Early physical medicine and rehabilitation for patients with acute respiratory failure: a quality improvement project // Archives of Phys. Med. Rehabil. 2010. Vol. 91, №4. Р.536-542.
  37. Petersen A.M., Pedersen B.K. The anti-inflammatory effect of exercise // J. Appl. Physiol. 2005. Vol. 98. P.1154-1162.
  38. Reid M.B. Response of the ubiquitin-proteasome pathway to changes in muscle activity // Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005. Р. 288.
  39. Schweickert W.D., Hall J. ICU-acquired weakness // Chest. 2007. Vol.131, №5. Р. 1541-1549.
  40. Shanely R.A., Zergeroglu M.A., Lennon S.L. et al. Mechanical ventilation-induced diaphragmatic atrophy is associated with oxidative injury and increased proteolytic activity // Am. J. Respir. Crit. Care. Med. 2002. Vol. 166, №10. Р. 1369-1374.
  41. Stein T.P., Wade C.E. Metabolic consequences of muscle disuse atrophy // J. Nutr. 2005. Vol.135, №7. Р. 1824-1828.
  42. Stevens R.D., Dowdy D.W., Michaels R.K. et al. Neuromuscular dysfunction acquired in critical illness: a systematic review // Intensive Care Med. 2007.Vol. 33, №11. Р. 1876-1891.
  43. Stevenson E.J., Giresi P.G., Koncarevic A., Kandarian S.C. Global analysis of gene expression patterns during disuse atrophy in rat skeletal muscle // J. Physiol. 2003.Vol.551. P.33-48.
  44. Taillandier D., Aurousseau E., Meynial-Denis D. et al. Coordinate activation of lysosomal, Ca 2+-activated and ATP-ubiquitin-dependent proteinases in the unweighted rat soleus muscle // Biochem. J. 1996. Vol. 316, P. 65-72.
  45. Thomsen G.E., Snow G.L., Rodriguez L., Hopkins R.O. Patients with respiratory failure increase ambulation after transfer to an intensive care unit where early activity is a priority // Crit. Care. Med. 2008. Vol. 36. P.1119-1124.
  46. Tidball J.G., Spencer M.J. Calpains and muscular dystrophies // Int. J. Biochem. Cell. Biol. 2000. Vol.32. P. 1-5.
  47. Truong A.D., Fan E., Brower R.G., Needham D.M. Bench-to-bedsidereview: mobilizing patients in the intensive care unit: from pathophysiology to clinical trials // Crit. Care. 2009. Vol.13, №4. Р. 216.
  48. Winkelman C. Inactivity and inflammation in the critically ill patient // Crit. Care. Clin. 2007. Vol.23, №1. Р. 21-34.
  49. Witt N.J., Zochodne D.W., Bolton C.F. et al. Peripheral nerve function in sepsis and multiple organ failure // Chest. 1991. Vol. 99. P.176-184.
  50. Zambon M., Vincent J-L. Mortality rates for patients with acute lung injury ARDS have decreased over time // Chest. 2008. Vol.133, №5. Р. 1120-1127.

Copyright (c) 2015 Gaifutdinov R.T.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies